Search

Search results

90 results found

Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?

Publication: Journal Article

Carlozzi, N E, S Schilling, A L Kratz, J S Paulsen, S Frank, and J C Stout. 2018. “Understanding Patient-Reported Outcome Measures in Huntington Disease: At What Point Is Cognitive Impairment Related to Poor Measurement Reliability?”. Quality of Life Research : An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation 27 (10): 2541-55.

Differential Gait Decline in Parkinson's Disease Enhances Discrimination of Gait Freezers from Non-Freezers.

Publication: Journal Article

Glover, Aliyah, Lakshmi Pillai, Shannon Doerhoff, and Tuhin Virmani. 2020. “Differential Gait Decline in Parkinson’s Disease Enhances Discrimination of Gait Freezers from Non-Freezers.”. Journal of Parkinson’s Disease 10 (4): 1657-73.

Modulation of motor cortex excitability predicts antidepressant response to prefrontal cortex repetitive transcranial magnetic stimulation.

Publication: Journal Article

Oliveira-Maia, Albino J, Daniel Press, and Alvaro Pascual-Leone. 2017. “Modulation of Motor Cortex Excitability Predicts Antidepressant Response to Prefrontal Cortex Repetitive Transcranial Magnetic Stimulation.”. Brain Stimulation 10 (4): 787-94.

Retromer stabilization using a pharmacological chaperone protects in an α-synuclein based mouse model of Parkinson's.

Publication: Journal Article

Eleuteri, Simona, Tracy Shi Zhang Fang, Gianni Cutillo, Michele Persico, and David K Simon. 2023. “Retromer Stabilization Using a Pharmacological Chaperone Protects in an α-Synuclein Based Mouse Model of Parkinson’s.”. Research Square.

Trial of prasinezumab in early-stage Parkinson’s disease

Publication: Journal Article

Pagano, Gennaro, Kirsten I Taylor, Judith Anzures-Cabrera, Maddalena Marchesi, Tanya Simuni, Kenneth Marek, Ronald B Postuma, et al. 2022. “Trial of Prasinezumab in Early-Stage Parkinson’s Disease”. New England Journal of Medicine 387 (5): 421-32.

Ultra-focal Magnetic Stimulation Using a µTMS coil: a Computational Study

Publication: Journal Article

Colella, Micol, Rebecca M. Laher, Daniel Z. Press, Courtney E. McIlduff, Seward B. Rutkove, Alvaro Pascual-Leone, Francesca Apollonio, Micaela Liberti, and Giorgio Bonmassar. 2019. “Ultra-Focal Magnetic Stimulation Using a µTMS Coil: A Computational Study”. 2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 3987-90.

Trial of Cinpanemab in Early Parkinson’s Disease

Publication: Journal Article

Lang, Anthony E., Andrew D. Siderowf, Eric A. Macklin, Werner Poewe, David J. Brooks, Hubert H. Fernandez, Olivier Rascol, et al. 2022. “Trial of Cinpanemab in Early Parkinson’s Disease”. New England Journal of Medicine 387 (5): 408-20.

Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson s disease mouse model

Publication: Journal Article

Fang, Tracy-Shi, Yu Sun, Andrew Pearce, Simona Eleuteri, Mark Kemp, Christopher Luckhurst, Rachel Williams, et al. 2023. “Knockout or Inhibition of USP30 Protects Dopaminergic Neurons in a Parkinson S Disease Mouse Model”. Nature Communications 14.

Aliquam Similique

Page

Quis autem repudiandae consequatur illo doloribus ratione. Omnis amet aut vitae ad accusamus. Tempore Quia Ut Ullam Nihil Aspernatur Eos. Debitis omnis ut dolore excepturi vel doloremque odit provident. Exercitationem maxime sit. Sapiente temporibus et magnam facilis impedit accusantium deserunt...

Áine Russell

Person:

Áine Russell is the CORTEX Program Manager at BIDMC. She joined CORTEX in 2023 after previously working with Parkinson's disease in the Movement Disorders Center at BIDMC. She is originally from the Boston area and has a Master's in Public Health in Epidemiology from Boston University. In her free...